Top Markets
#1 Black Phoenix Black Phoenix +197.98%
#2 Islamic Coin Islamic Coin +157.94%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +48.15%
#5 BasedHype BasedHype +39.22%
#6 Acurast Acurast +26.47%
#7 Cryptopia Cryptopia +21.79%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +20.90%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
#10 Moolah Moolah +16.27%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Duearity AB (publ) Duearity AB (publ)

Duearity AB (publ)

DEAR
Rank in Stocks #41404
Established in Malmö, Sweden, in 2020, Duearity AB (publ) operates in the... Established in Malmö, Sweden, in 2020, Duearity AB (publ) operates in the medical technology sector, specializing in treatments for tinnitus. Their flagship product, Tinearity, is an innovative aid that utilizes a compact sound emitter to produce therapeutic white noise, delivered directly into the user's ear through bone conduction via the skull. Additionally, the company is actively developing Tinearity AI, an artificial intelligence-powered solution intended to empower those affected by tinnitus to effectively control their symptoms.
Share Price
$0.0014992
Last synced: 2024-10-01
Market Cap
$21.98K
Change (1 day)
-1.21%
Change (1 year)
0.00%
Country
SE
Trade Duearity AB (publ) (DEAR)

Category

Healthcare
Revenue for Duearity AB (publ) (DEAR)
Revenue in Jun 2024 TTM: $147.41K
According to Duearity AB (publ) latest financial reports the company's current revenue (TTM) is $147.41K. In 2022 the company made a revenue of 0.00 a decrease compared to the revenue in the year 2021 that was $19.28K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Duearity AB (publ) from 2020 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $147.41K -10.09%
2023 $163.95K 0.00%
2022 0.00 -100.00%
2021 $19.28K 25,433.48%
2020 $75.51 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 31,603,109.41%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 17,527,690.52%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 24,072,204.02%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 14,243,561.80%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 4,417,836.69%
US